Towards better TB control: Re-imagining public-private partnerships, Pg 6

TB Burden & Current System Limitations

• India contributes 25% to global TB burden; 2.8 million new cases/year.
• Over 50% seek private care; public sector lacks comfort, private sector lacks standard protocols.

Modified Care Model & PPP Benefits

• Collaboration enables standard protocols, better compliance and follow-up.
• Diagnostics, medicine access, and affordability addressed through regulated partnerships.

Drug Resistance & Regulation Needs

• Anti-TB drugs for resistance only in govt hospitals; strict admission protocols.
• Need for lab regulation, standardized reporting, and unregistered practitioners oversight.

Analysis & Way Forward

• PPP models with clearly defined protocols can ensure better care and outcome consistency.
• Invest in labs, logistics, and drug regulation to close systemic gaps.

Mains Mock Question:

"Evaluate the role of public-private partnerships in tuberculosis control in India. What are the challenges and how can accountability be ensured?"